Skip to main content
OpenTrials
Completed

NCT Number: NCT02434302

Characteristics and Outcomes of Childhood Moyamoya in the UK

This is a study to ascertain the number of children with moyamoya in the UK, their presenting features, clinical course and outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Great Ormond Street Hospital for CHidlren NHS Foundation Trust

London, WC1N 3LU, United Kingdom

About this study

The study ahs 3 components:

  • Patient identification via the British Paediatric Surveillance Unit, and the 21 collaborating centres
  • Record review/patient interview to determine clinical features & outcomes
  • Centralised review of imaging data to ascertain radiological phenotypes

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Radiological diagnosis of moyamoya

Exclusion criteria

  • Refuse consent

Treatment and study plan

Primary outcomes

  1. Number of children with moyamoya in UK

    Time frame: 2 years

Secondary outcomes

  1. clinical features & outcomes of childhood moyamoya

    Time frame: 2 years

  2. radioplogical features of childhood Moyamoya

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Great Ormond Street Hospital for Children NHS Foundation Trust

Other

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
May 5, 2015
Registry last updated
Dec 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.